It has been postulated that as a partial CB1/CB2 agonist that therefore does not elicit maximal stimulation of the receptor, THC could block endogenous, full agonists from binding to CB1 receptors in situations of high endocannabinoid tone, as seen in obesity [21]. Here, CNR2 is linked to obesity disorder.